get a key
steadybase-$ company GLMD
account_id none on file
legal_name Galmed Pharmaceuticals Ltd.
ticker GLMD
cik 1595353
domain galmedpharma.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 7 executives 5 family 0
why_nownone on file
callsnone on file
filings
Stenzler joined the Company in June 2014 as the Company’s corporate controller, and later on served as the Company’s Director of Finance.

filing / Mar 31, 2026 / receipt

Simultaneously, we initiated a cost reduction plan and at various times in the past have conducted a strategic review process.

filing / Mar 31, 2026 / receipt

Allen Baharaff | 61 | President and Chief Executive Officer, Class II Director

filing / Mar 31, 2026 / receipt

Dr. Liat Hayardeny | 59 | Chief Scientist Officer

filing / Mar 31, 2026 / receipt

Doron Cohen | 59 | Chief Financial Officer

filing / Mar 31, 2026 / receipt

Yohai Stenzler | 43 | Chief Accounting Officer

filing / Mar 31, 2026 / receipt

Guy Nehemya | 41 | Chief Operating Officer and Data Protection Officer

filing / Mar 31, 2026 / receipt

executives
Allen Baharaff President and Chief Executive Officer, Class II Director - receipt
Doron Cohen Chief Financial Officer - receipt
Dr. Liat Hayardeny Chief Scientist Officer - receipt
Guy Nehemya Chief Operating Officer and Data Protection Officer - receipt
Yohai Stenzler Chief Accounting Officer (CAO) linkedin receipt
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
steadybase-$